Announcements Trials
Browse Landscape

Phase

Phase NA 220Phase 2 14Phase 3 8Phase 1 6Phase 1/2 4Phase 4 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Withdrawn 1Terminated 1Suspended 1Recruiting 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 97Prostatic Neoplasms 41Neoplasms 40Glioblastoma 26Melanoma 24Head and Neck Neoplasms 24Brain Neoplasms 24Ovarian Neoplasms 18Squamous Cell Carcinoma of Head and Neck 17Lung Neoplasms 17Carcinoma, Renal Cell 17Carcinoma, Hepatocellular 17Glioma 16Pancreatic Neoplasms 15Carcinoma, Non-Small-Cell Lung 15Leukemia, Myeloid, Acute 14Colorectal Neoplasms 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Urinary Bladder Neoplasms 10Lymphoma 10Uterine Cervical Neoplasms 9Polycystic Ovary Syndrome 9Lymphoma, Non-Hodgkin 9Fallopian Tube Neoplasms 9Endometrial Neoplasms 9Myelodysplastic Syndromes 8Multiple Myeloma 8Lymphoma, Mantle-Cell 8Lymphoma, Large B-Cell, Diffuse 8Skin Neoplasms 7

Interventions

Psilocybin 1Niacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Completed × Anxiety Disorders × Clear all
NCT00957359 2020-10-20

Psilocybin Cancer Anxiety Study

NYU Langone Health

Phase EARLY_PHASE1 Completed
29 enrolled 59 charts

Anxiety Disorders, Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡